ACE-031 1MG

ACE-031 10MG | Soluble Activin Receptor Type IIB (ACVR2B-Fc)

Elite-grade recombinant fusion protein for advanced musculoskeletal and neuromuscular research.

ACE-031 is a soluble form of the activin receptor type IIB (ACVR2B), engineered to act as a potent decoy receptor. In the field of advanced myology, this compound is studied for its ability to bind to proteins like Myostatin (GDF-8) and Activin A before they can attach to endogenous receptors, thereby facilitating research into the negative regulation of muscle mass.

Research Benchmarks: Hypertrophic Signaling & Bone Density

Peer-reviewed studies utilize ACE-031 to investigate the complex pathways of muscle wasting and metabolic homeostasis:

• Myostatin Inhibition: Studying the neutralization of GDF-8 to evaluate the potential for significant skeletal muscle hypertrophy.
• Bone Morphogenesis: Investigating the secondary effects on bone mineral density and the prevention of osteopenia in research models.
• Adipose Modulation: Researching the correlation between increased muscle mass and the reduction of systemic fat mass.

Scientific Reference Library

Explore the molecular foundations and therapeutic potential of ACE-031 through these authoritative search results on PubMed:

• 🧪 Research: ACE-031 and the modulation of the Myostatin pathway
• 🧪 Research: Soluble activin receptor type IIB (ACVR2B-Fc) and skeletal muscle growth
• 🧪 Research: ACE-031 applications in neuromuscular disease models

Analytical Specifications